Phibro Animal Health price target lowered to $10 from $17 at Barclays

Barclays lowered the firm’s price target on Phibro Animal Health to $10 from $17 and keeps an Underweight rating on the shares. The company’s fiscal Q1 revenue missed estimates and it is targeting ways to cut spend for investments as macro pressures persist, the analyst tells investors in a research note.